Samuel J Rodgers

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Cell Proliferation

Duchenne Muscular Dystrophy

Top Venues

The EMBO journal

Molecular & cellular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Harrison M York, Kunaal Joshi, Charles S Wright, Laura Z Kreplin, Samuel J Rodgers, Ullhas K Moorthi, Hetvi Gandhi, Abhishek Patil, Christina A Mitchell, Srividya Iyer-Biswas, Senthil Arumugam
Deterministic early endosomal maturations emerge from a stochastic trigger-and-convert mechanism. Nature communications 14 (1) (2023)
Samuel J Rodgers, Lisa M Ooms, Christina A Mitchell
The FDA-Approved Drug Pyrvinium Selectively Targets ER + Breast Cancer Cells with High INPP4B Expression. Cancers 15 (1) (2022)
Samuel J Rodgers, Lisa M Ooms, Christina A Mitchell
The FDA-Approved Drug Pyrvinium Selectively Targets ER + Breast Cancer Cells with High INPP4B Expression. Cancers 15 (1) (2022)
Samuel J Rodgers, Emily I Jones, Senthil Arumugam, Sabryn A Hamila, Jill Danne, Rajendra Gurung, Matthew J Eramo, Randini Nanayakkara, Georg Ramm, Meagan J McGrath, Christina A Mitchell
Endosome maturation links PI3Kα signaling to lysosome repopulation during basal autophagy. The EMBO journal 41 (19) (2022)
Samuel J Rodgers, Emily I Jones, Christina A Mitchell, Meagan J McGrath
Sequential conversion of PtdIns3P to PtdIns(3,5)P 2 via endosome maturation couples nutrient signaling to lysosome reformation and basal autophagy. Autophagy (2022)
Samuel J Rodgers, Lisa M Ooms, Christina A Mitchell
The FDA-Approved Drug Pyrvinium Selectively Targets ER + Breast Cancer Cells with High INPP4B Expression. Cancers 15 (1) (2022)
Randini Nanayakkara, Rajendra Gurung, Samuel J Rodgers, Matthew J Eramo, Georg Ramm, Christina A Mitchell, Meagan J McGrath
Autophagic lysosome reformation in health and disease. Autophagy (2022)
Samuel J Rodgers, Sabryn A Hamila, Christina A Mitchell, Lisa M Ooms
A late endosome signaling hub that couples PI3Kα and WNT/β-catenin signaling in breast cancer. Molecular & cellular oncology 8 (4) (2021)